Lanean...
Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in colon carcinoma cells
p97 has recently emerged as a therapeutic target for cancer due to its essential functions in protein homeostasis. CB-5083 is a first-in-class, potent and selective ATP-competitive p97 inhibitor that induces proteotoxic stress in cancer cells. Potential mechanisms regulating the sensitivity of cells...
Gorde:
| Argitaratua izan da: | Cell Cycle |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469669/ https://ncbi.nlm.nih.gov/pubmed/32423265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1754584 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|